McClain, Micah T. http://orcid.org/0000-0001-8034-1136
Constantine, Florica J.
Henao, Ricardo
Liu, Yiling
Tsalik, Ephraim L.
Burke, Thomas W.
Steinbrink, Julie M.
Petzold, Elizabeth
Nicholson, Bradly P.
Rolfe, Robert
Kraft, Bryan D.
Kelly, Matthew S.
Saban, Daniel R.
Yu, Chen
Shen, Xiling
Ko, Emily M.
Sempowski, Gregory D.
Denny, Thomas N.
Ginsburg, Geoffrey S.
Woods, Christopher W.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U01AI066569)
United States Department of Defense | Defense Advanced Research Projects Agency (N66001-09-C-2082)
U.S. Department of Veterans Affairs (1 I01 CX001850)
Article History
Received: 25 June 2020
Accepted: 15 January 2021
First Online: 17 February 2021
Competing interests
: M.T.M., E.L.T., T.W.B., G.S.G., and C.W.W. have patents pending on Molecular Methods to Diagnose and Treat Respiratory Infections. E.L.T., G.S.G., and C.W.W. are co-founders of Predigen, Inc. T.W.B. is a consultant for and holds equity in Predigen, Inc. All other authors declare no competing interests.